Open Access
Review
The Application of Artificial Intelligence in the Research and Development of Traditional Chinese Medicine
Zhipeng Ke1, 2
, Minxuan Liu1, 2, 3
, Jing Liu1, 2
, Zhenzhen Su1, 2
, Lu Li1, 2
, Mengyu Qian1, 2
, Xinzhuang Zhang1, 2
, Liang Cao1, 2
, Tuanjie Wang1, 2
, Zhenzhong Wang1, 2
, Wei Xiao1, 2, *
Author Information
Submitted: 4 Sept 2023 | Accepted: 4 Nov 2023 | Published: 18 Mar 2024
Abstract
With the accumulation of data in the pharmaceutical industry and the development of artificial intelligence technology, various artificial intelligence methods have been successfully employed in the drug discovery process. The integration of artificial intelligence in Traditional Chinese medicine has also gained momentum, encompassing quality control of Chinese patent medicines, prescriptions optimization, discovery of effective substances, and prediction of side effects. However, artificial intelligence also faces challenges and limitations in Traditional Chinese medicine development, such as data scarcity and complexity, lack of interdisciplinary professionals, black-box models, etc. Therefore, more research and collaboration are needed to address these issues and explore the best ways to integrate artificial intelligence and Traditional Chinese medicine to improve human health.
Keywords
References
1.
Wang, S.; Hou, Y.; Li, X.; et al. Practical implementation of artificial intelligence-based deep learning and cloud computing on the application of traditional medicine and western medicine in the diagnosis and treatment of rheumatoid arthritis. Front. Pharm. 2021, 12, 765435.
2.
Wang, X.; Wang, Z.Y.; Zheng, J.H.; et al. TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches. Chin. J. Nat. Med. 2021, 19, 1‒11.
3.
Zhai, X.; Wang, Q.; Li, M. Tu Youyou’s Nobel Prize and the academic evaluation system in China. Lancet 2016, 387, 1722.
4.
An, X.; Zhang, Y.; Duan, L.; et al. The direct evidence and mechanism of Traditional Chinese medicine treatment of COVID-19. Biomed. Pharmacother. 2021, 137, 111267.
5.
Wang, W.Y.; Xie, Y.; Zhou, H.; et al. Contribution of Traditional Chinese medicine to the treatment of COVID-19. Phytomedicine 2021, 85, 153279.
6.
Wei, Z.; Chen, J.; Zuo, F.; et al. Traditional Chinese medicine has great potential as candidate drugs for lung cancer: A review. J. Ethnopharmacol. 2023, 300, 115748.
7.
Zhang, B.; Wang, X.; Li, S. An integrative platform of tcm network pharmacology and its application on a herbal formula, Qing-Luo-Yin. Evid. Based Complement. Alternat. Med. 2013, 2013, 456747.
8.
Li, N.; Yu, J.; Mao, X.; et al. The research and development thinking on the status of artificial intelligence in Traditional Chinese medicine. Evid. Based Complement. Alternat. Med. 2022, 2022, 7644524.
9.
Yang, X.; Wang, Y.; Byrne, R.; et al. Concepts of artificial intelligence for computer-assisted drug discovery. Chem. Rev., 2019, 119, 10520‒10594.
10.
Zhong, F.; Xing, J.; Li, X.; et al. Artificial intelligence in drug design. Sci. China Life Sci., 2018, 61, 1191‒1204.
11.
Tripathi, M.K.; Nath, A.; Singh, T.P.; et al. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Mol. Divers. 2021, 25, 1439‒1460.
12.
Jang, S.H.; Sivakumar, D.; Mudedla, S.K.; et al. PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia. Front. Mol. Biosci. 2022, 9, 1072028.
13.
Zou, Y.; Shi, Y.; Sun, F.; et.al. Extreme gradient boosting model to assess risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual prediction using SHapley Additive exPlanations. Comput. Methods Programs Biomed. 2022, 225, 107038.
14.
Zhang, H.; Ni, W.; Li, J.; et al. Artificial intelligence-based traditional Chinese medicine Assistive Diagnostic System: Validation Study. JMIR Med. Inform. 2020, 8, e17608.
15.
Zhang, B.; Pei, W.; Cai, P.; et al. Recent advances in Chinese patent medicines entering the international market. Drug Discoveries Ther. 2022, 16, 258‒272.
16.
Chen, H.; He, Y. Machine learning approaches in Traditional Chinese medicine: A systematic review. Am. J. Chin. Med. 2022, 50, 91‒131.
17.
Xue, Q.L.; Miao, K.H.; Yu, Y.; et al. Methodology for adaptive decision--making research on manufacturing process of Traditional Chinese medicine based on deep reinforcement learning. Zhong guo Zhong Yao Za Zhi, 2023, 48, 562‒568.
18.
He, X.; Huang, S.; Wu, M.; et al. Simultaneous quantitative analysis of ten bioactive flavonoids in Citri Reticulatae Pericarpium Viride (Qing Pi) by ultrahigh-performance liquid chromatography and high-resolution mass spectrometry combined with chemometric methods. Phytochem. Anal. 2021, 32, 1152‒1161.
19.
Bai, C.; Yang, J.; Cao, B.; et al. Growth years and post-harvest processing methods have critical roles on the contents of medicinal active ingredients of Scutellaria baicalensis. Ind. Crops. Prod. 2020, 158, 112985.
20.
Zeng, P.; Li, J.; Chen, Y.; et al. The structures and biological functions of polysaccharides from traditional Chinese herbs. Prog. Mol. Biol. Transl. Sci., 2019, 163, 423‒444.
21.
Tan, C.; Wu, C.; Huang, Y.; et al. Identification of different species of Zanthoxyli Pericarpium based on convolution neural network. PLoS One 2020, 15, e0230287.
22.
Wang, Y.; Xiong, F.; Zhang, Y.; et al. Application of hyperspectral imaging assisted with integrated deep learning approaches in identifying geographical origins and predicting nutrient contents of Coix seeds. Food Chem. 2023, 404, 134503.
23.
Yue, J.; Li, Z.; Zuo, Z.; et al. Study on the identification and evaluation of growth years for Paris polyphylla var. yunnanensis using deep learning combined with 2DCOS. Spectrochim. Acta, Part A 2021, 261, 120033.
24.
Zhang, Y.; Wang, C.; Wang, Y.; et al. Determining the stir-frying degree of gardeniae fructus praeparatus based on deep learning and transfer learning. Sensors 2022, 22, 8091.
25.
Wang, J.; Mo, W.; Wu, Y.; et al. Combined channel attention and spatial attention module network for chinese herbal slices automated recognition. Front. Neurosci. 2022, 16, 920820.
26.
Zhao, J.; Tian, G.; Qiu, Y.; et al. Rapid quantification of active pharmaceutical ingredient for sugar-free Yangwei granules in commercial production using FT-NIR spectroscopy based on machine learning techniques. Spectrochim. Acta, Part A 2021, 245, 118878.
27.
Han, Y.; Zhou, M.; Wang, L.; et al. Comparative evaluation of different cultivars of Flos Chrysanthemi by an anti-inflammatory-based NF-kappaB reporter gene assay coupled to UPLC-Q/TOF MS with PCA and ANN. J. Ethnopharmacol. 2015, 174, 387‒395.
28.
Guo, J.; Zhang, L.; Shang, Y.; et al. A strategy for intelligent chemical profiling-guided precise quantitation of multi-components in Traditional Chinese medicine formulae-QiangHuoShengShi decoction. J. Chromatogr. A. 2021, 1649, 462178.
29.
Zhong, F.; Wu, X.; Yang, R.; et al. Drug target inference by mining transcriptional data using a novel graph convolutional network framework. Protein Cell 2022, 13, 281‒301.
30.
Zhu, H. Big data and artificial intelligence modeling for drug discovery. Annu. Rev. Pharmacol. Toxicol. 2020, 60, 573‒589.
31.
Beck, B.R.; Shin, B.; Choi, Y.; et al. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput. Struct. Biotechnol. J. 2020, 18, 784‒790.
32.
Serafim, M.S.M.; Kronenberger, T.; Oliveira, P.R.; et al. The application of machine learning techniques to innovative antibacterial discovery and development. Expert. Opin, Drug Discov. 2020, 15, 1165‒1180.
33.
Spiegel, J.O.; Durrant, J.D. AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization. J. Cheminform. 2020, 12, 25.
34.
Karimi, M.; Wu, D.; Wang, Z.; et al. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks. Bioinformatics 2019, 35, 3329‒3338.
35.
Lu, S.H.; Zhang, M.C.; Zhai, H.L.; et al. Rapid determination in the quality control of Chinese patent medicine. J. Pharm. Innov. 2022, 17, 1305‒1313.
36.
Keji, C.; Bei, Y. Certain progress of clinical research of Chinese integrative medicine. Chin. Med. J. 1999, 112, 934‒937.
37.
Leong, F.; Hua, X.; Wang, M.; et al. Quality standard of Traditional Chinese medicines: comparison between European Pharmacopoeia and Chinese Pharmacopoeia and recent advances. Chin. Med. 2020, 15, 76.
38.
Luo, H.; Zhao, Y.; Hua, H.; et al. Research progress on quality assurance of genuine Chinese medicinal in Sichuan. Chin. Med. 2021, 16, 19.
39.
Huang, L.; Xie, D.; Yu, Y.; et al. TCMID 2.0: A comprehensive resource for TCM. Nucleic. Acids. Res. 2018, 46, D1117‒D1120.
40.
Li, D.; Hu, J.; Zhang, L.; et al. Deep learning and machine intelligence: New computational modeling techniques for discovery of the combination rules and pharmacodynamic characteristics of Traditional Chinese medicine. Eur. J. Pharmacol. 2022, 933, 175260.
41.
Gupta, R.; Srivastava, D.; Sahu, M.; et al. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol. Divers. 2021, 25, 1315‒1360.
42.
Li, S.; Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin. J. Nat. Med. 2013, 11, 110‒120.
43.
Chen, H.; Huang, Y.; Liu, H.; et al. Research progress on the mechanism of reducing toxicity and increasing the efficacy of sini decoction compatibility. Chem. Pharm. Bull. 2022, 70, 827‒838.
44.
Zhou, W.; Yang, K.; Zeng, J.; et al. FordNet: Recommending traditional Chinese medicine formula via deep neural network integrating phenotype and molecule. Pharmacol. Res. 2021, 173, 105752.
45.
Dong, X.; Zheng, Y.; Shu, Z.; et al. TCMPR: TCM prescription recommendation based on subnetwork term mapping and deep learning. Biomed. Res. Int. 2022, 2022, 4845726.
46.
Ren, X.; Guo, Y.; Wang, H.; et al. The intelligent experience inheritance system for Traditional Chinese medicine. J. Evid. Based. Med. 2023, 16, 91‒100.
47.
Zhao, W.; Lu, W.; Li, Z.; et. al. TCM herbal prescription recommendation model based on multi-graph convolutional network. J. Ethnopharmacol. 2022, 297, 115109.
48.
Liu, Z.; Luo, C.; Fu, D.; et al. A novel transfer learning model for traditional herbal medicine prescription generation from unstructured resources and knowledge. Artif. Intell. Med. 2022, 124, 102232.
49.
Lan, Z.; Chen, M.; Goodman, S.; et al. ALBERT: A lite bert for self-supervised learning of language Representations. arXiv preprint arXiv 2019, 1909, 11942. https://doi.org/10.48550/arXiv.1909.11942.
50.
Jin, Y.; Ji, W.; Shi, Y.; et al. Meta-path guided graph attention network for explainable herb recommendation. Health. Inf. Sci. Syst. 2023, 11, 5.
51.
Parvez, M.K.; Rishi, V. Herb-Drug Interactions and Hepatotoxicity. Curr. Drug Metab. 2019, 20, 275‒282.
52.
Zhuang, T.; Gu, X.; Zhou, N.; et al. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): How to properly control the “General (Jiang Jun)” in Chinese medical herb. Biomed. Pharmacother. 2020, 127, 110224.
53.
Ni, B.; Liu, Y.; Gao, X.; et al. Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 2022, 261, 109430.
54.
Wang, Z.; Li, L.; Song, M.; et al. Evaluating the Traditional Chinese medicine (TCM) Officially Recommended in China for COVID-19 Using Ontology-Based Side-Effect Prediction Framework (OSPF) and Deep Learning. J. Ethnopharmacol. 2021, 272, 113957.
55.
Chen, Z.; Zhao, M.; You, L.; et al. Developing an artificial intelligence method for screening hepatotoxic compounds in Traditional Chinese medicine and Western medicine combination. Chin. Med. 2022, 17, 58.
56.
Tran, T.T.V.; Surya, Wibowo A.; Tayara, H.; et al. Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives. J. Chem. Inf. Model. 2023, 63, 2628‒2643.
57.
Kha, Q.H.; Le, V.H.; Hung, T.N.K.; et al. Development and Validation of an Explainable Machine Learning-Based Prediction Model for Drug-Food Interactions from Chemical Structures. Sensors 2023, 23, 3962.
58.
Xie, Y.; Mai, C.T.; Zheng, D.C.; et al. Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of Traditional Chinese medicine. Phytomedicine 2021, 85, 153522.
59.
Wang, P.; Guo, W.; Huang, G.; et al. Berberine-Based heterogeneous linear supramolecules neutralized the acute nephrotoxicity of aristolochic acid by the self-assembly strategy. ACS Appl. Mater. Interfaces. 2021, 13, 32729‒32742.
60.
Kuenzi, B.M.; Park, J.; Fong, S.H.; et al. Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell 2020, 38, 672‒684.e6.
61.
Cheng, F.; Kovacs, I.A.; Barabasi, A.L. Network-based prediction of drug combinations. Nat. Commun. 2019, 10, 1197.
62.
Wang, Y.; Yang, H.; Chen, L.; et al. Network-based modeling of herb combinations in Traditional Chinese medicine. Brief. Bioinform. 2021, 22, bbab106.
63.
Ianevski, A.; Giri, A.K.; Aittokallio, T. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic. Acids. Res. 2022, 50, W739‒W743.
64.
Preuer, K.; Lewis, R.P.I.; Hochreiter, S.; et al. DeepSynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics 2018, 34, 1538‒1546.
65.
Alsherbiny, M.A.; Radwan, I.; Moustafa, N.; et al. Trustworthy deep neural network for inferring anticancer synergistic combinations. IEEE J. Biomed. Health Inform. 2023, 27, 1691‒1700.
66.
Liu, H.; Zhang, W.; Zou, B.; et al. DrugCombDB: A comprehensive database of drug combinations toward the discovery of combinatorial therapy. Nucleic. Acids. Res. 2020, 48, D871‒D881.
67.
Zhang, T.; Zhang, L.; Payne, P.R.O.; et al. Synergistic drug combination prediction by integrating multiomics data in deep learning models. Methods Mol Biol. 2021, 2194, 223‒238.
68.
Nguyen, T.M.; Quinn, T.P.; Nguyen, T.; et al. Explaining black box drug target prediction through model agnostic counterfactual samples. IEEE/ACM Trans. Comput. Biol. Bioinform. 2023, 20, 1020‒1029.
69.
Vo, T.H.; Nguyen, N.T.K.; Kha, Q.H.; et al. On the road to explainable AI in drug-drug interactions prediction: A systematic review. Comput. Struct. Biotechnol. J. 2022, 20, 2112‒2123.
70.
Nguyen, H.S.; Ho, D.K.N.; Nguyen, N.N.; et al. Predicting EGFR mutation status in non-small cell lung cancer using artificial intelligence: a systematic review and meta-analysis. Acad. Radiol. 2023.
71.
Wojtara, M.; Rana, E.; Rahman, T.; et al. Artificial intelligence in rare disease diagnosis and treatment. Clin. Transl. Sci. 2023, 16, 2106‒2111
72.
Chen, Z.H.; Lin, L.; Wu, CF.; et al. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun. 2021, 41, 1100‒1115.
73.
Blasiak, A.; Khong, J.; Kee, T. CURATE.AI: Optimizing personalized medicine with artificial intelligence. SLAS. Techno. 2020, 25, 95‒105.
Issue
Volume 3, Issue 1How to Cite
Ke, Z., Liu, M., Liu, J., Su, Z., Li, L., Qian, M., Zhang, X., Cao, L., Wang, T., Wang, Z., & Xiao, W. (2024). The Application of Artificial Intelligence in the Research and Development of Traditional Chinese Medicine. International Journal of Drug Discovery and Pharmacology, 3(1), 100001. https://doi.org/10.53941/ijddp.2024.100001
RIS
BibTex
Copyright & License
Copyright (c) 2024 by the authors.
This work is licensed under a This work is licensed under a Creative Commons Attribution 4.0 International License.